Search

Your search keyword '"Bogdanos, Dimitrios"' showing total 1,406 results
Start Over Author "Bogdanos, Dimitrios"
1,406 results on '"Bogdanos, Dimitrios"'

3. Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases

Author

Papagoras, Charalampos, Zioga, Nikoleta, Papadopoulos, Vasileios, Gerolymatou, Nafsika, Kalavri, Eleni, Bounos, Christos, Simopoulou, Theodora, Fragoulis, George E., Panopoulos, Stylianos, Fragiadaki, Kalliopi, Evangelatos, Gerasimos, Bournia, Vasiliki-Kalliopi, Arida, Aikaterini, Karamanakos, Anastasios, Pappa, Maria, Kravvariti, Evrydiki, Deftereou, Kleopatra, Kougkas, Nikolaos, Zampeli, Evangelia, Kataxaki, Evangelia, Melissaropoulos, Konstantinos, Barouta, Georgia, Panagiotopoulos, Alexandros, Koutsianas, Christos, Liossis, Stamatis-Nick, Georgiou, Panagiotis, Dimitroulas, Theodoros, Tektonidou, Maria G., Bogdanos, Dimitrios P., Elezoglou, Antonia, Voulgari, Paraskevi V., Sfikakis, Petros P., and Vassilopoulos, Dimitrios

Published
2023
Full Text
View/download PDF

4. Contributors

Author

Abu-Shakra, Mahmoud, primary, Adiguzel, Yekbun, additional, Al Shawaf, Maisam, additional, Alghory, Amal, additional, Almeida, Isabel, additional, Alrais, Mahmoud, additional, Alrifaai, Mohamad Aosama, additional, Alwani, Abdulkarim, additional, Alwani, Abdulrahman, additional, Amital, Howard, additional, Anna, Dubaniewicz, additional, Arleevskaya, Marina, additional, Ashkenazi, Shai, additional, Athanassiou, Lambros, additional, Athanassiou, Panagiotis, additional, Atik, Houda, additional, Atzeni, Fabiola, additional, Balbir-Gurman, Alexandra, additional, Balcioglu, Zeynep Betul, additional, Baldini, Chiara, additional, Barbour, Mohammad, additional, Bashi, Tomer, additional, Belyaeva, Irina V., additional, Ben-Ami, Dana, additional, Blank, Miri, additional, Boccassini, Laura, additional, Bogdanos, Dimitrios P., additional, Bombardieri, Stefano, additional, Bost, Chloé, additional, Brandão, Mariana, additional, Braun-Moscovici, Yolanda, additional, Brooks, Wesley H., additional, Campar, A., additional, Carvalheiras, Graziela, additional, Cervera, R., additional, Churilov, Leonid P., additional, Cohen, Eytan, additional, Correia, J., additional, Darkhabani, Mohammad, additional, David, Paula, additional, de Carvalho, Jozélio Freire, additional, Deniz, Omer Faruk, additional, Detrick, Barbara, additional, Deutsch, Melanie, additional, Di Battista, Marco, additional, Dogan, Emir, additional, Dogru, Omer Faruk, additional, Domingues, Vital Da Silva, additional, Dotan, Arad, additional, Dow, Coad Thomas, additional, Durai, Malarvizhi, additional, Elefante, Elena, additional, Elsalti, Abdulrahman, additional, Erman, Mikhail V., additional, Esirgun, Sevval Nil, additional, Ferrão, C., additional, Ferreira, Álvaro, additional, Ferro, Francesco, additional, Fonseca, Tomás, additional, Garg, Ravindra Kumar, additional, Guilherme, Luiza, additional, Habra, Mona, additional, Halpert, Gilad, additional, Hammerstad, Sara Salehi, additional, Hooks, John J., additional, Ilchovska, Daisy, additional, Invernizzi, Pietro, additional, Israeli, E., additional, Janket, Sok-Ja, additional, Kalil, Jorge, additional, Karaoglan, Birnur Sinem, additional, Kiyak, Zeynep, additional, Kol, Mustafa Yusuf, additional, Kostoglou-Athanassiou, Ifigenia, additional, Krause, Ilan, additional, Kudryavtsev, Igor V., additional, Kumar, Neeraj, additional, Lavine, Noy, additional, Lerman, Tsahi T., additional, Levi, Assi, additional, Ling, Eduard, additional, Moutsopoulos, Haralampos M., additional, Mahajna, Hussein, additional, Mahroum, Naim, additional, Malhotra, Hardeep Singh, additional, Malkova, Аnna M., additional, Maoz-Segal, Ramit, additional, Marinho, António, additional, Mavragani, Clio P., additional, Meurman, Jukka H., additional, Milhes, Jean, additional, Mimouni, Daniel, additional, Morais, Cátia Iracema, additional, Moudgil, Kamal D., additional, Muniz Caldas, Cezar Augusto, additional, Neves, Esmeralda, additional, Neyestani, Kamyar, additional, Nikolaev, Alexei V., additional, Noversa de Sousa, Rita, additional, Ohayon, Aviran, additional, Palumbo, Antonino, additional, Pasoto, Sandra Gofinet, additional, Petríková, Jana, additional, Puxeddu, Ilaria, additional, Raftopoulou, Sylvia, additional, Renaudineau, Yves, additional, Ribeiro, Francinne Machado, additional, Rigopoulou, Eirini I., additional, Rosário, Cristina, additional, Rossa, Alessandra Della, additional, Sahin, Meyha, additional, Sarzi-Puttini, Piercarlo, additional, Seguro, Luciana Parente Costa, additional, Seida, Isa, additional, Seida, Ravend, additional, Serpa Pinto, L., additional, Sharon, Eran, additional, Shoenfeld, Yehuda, additional, Smyk, Daniel S., additional, Sousa, Rita Catarina Medeiros, additional, Starshinova, Anna A., additional, Tamimi, Faleh, additional, Tocut, Milena, additional, Tomer, Yaron, additional, Tunitsky-Lifshitz, Yulia, additional, Vasconcelos, Carlos, additional, Vasconcelos, Júlia, additional, Vassilopoulos, Dimitrios, additional, Venkatesha, Shivaprasad H., additional, Villanueva, Ronald, additional, Vita, Pedro, additional, Yablonskiy, Piotr K., additional, Yilmaz, Mesut, additional, Zamorano, Bryan, additional, Zandman-Goddard, Gisele, additional, Zinchenko, Yulia S., additional, and Zoubi, Magdi, additional

Published
2024
Full Text
View/download PDF

11. Apremilast for biologic-naïve, peripheral psoriatic arthritis, including patients with early disease: results from the APROACH observational prospective study

Author

Sfikakis, Petros P., Vassilopoulos, Dimitrios, Katsifis, Gkikas, Vosvotekas, Georgios, Dimitroulas, Theodoros, Sidiropoulos, Prodromos, Vounotrypidis, Periklis, Bogdanos, Dimitrios P., Georgountzos, Athanasios Ι., Bounas, Andreas G., Georgiou, Panagiotis, Gazi, Souzana, Kataxaki, Evangelia, Liossis, Stamatis-Nick, Theodorou, Evangelos, Papagoras, Charalampos, Theotikos, Evangelos, Vlachoyiannopoulos, Panayiotis, Voulgari, Paraskevi V., Kekki, Angeliki, Antonakopoulos, Nikolaos, and Boumpas, Dimitrios T.

Published
2023
Full Text
View/download PDF

13. Molecular mimicry and SARS-CoV-2

Author

Rigopoulou, Eirini I., primary, Dotan, Arad, additional, Efthymiou, Georgios, additional, Dardiotis, Efthymios, additional, Shoenfeld, Yehuda, additional, and Bogdanos, Dimitrios P., additional

Published
2023
Full Text
View/download PDF

14. List of contributors

Author

Adiguzel, Yekbun, primary, Andreoli, Laura, additional, Antonelli, Eleonora, additional, Athanassiou, Lambros, additional, Athanassiou, Panagiotis, additional, Avčin, Tadej, additional, Babel, Nina, additional, Bechmann, Nicole, additional, Benzvi, Carina, additional, Bitsadze, Victoria, additional, Bogdanos, Dimitrios P., additional, Bonam, Srinivsasa Reddy, additional, Borba, Vânia, additional, Borghi, M.O., additional, Bornstein, Stefan R., additional, Bragazzi, Nicola Luigi, additional, Carrera-Bastos, Pedro, additional, Churilov, Leonid P., additional, Crisafulli, Francesca, additional, Cruz-Domínguez, María Pilar, additional, Cugno, M., additional, Danieli, MariaGiovanna, additional, Dardiotis, Efthymios, additional, David, Paula, additional, Davidy, Tal, additional, Della-Pina, Silvia-Ebe-Lucia, additional, Dotan, Arad, additional, Dragon-Durey, Marie-Agnès, additional, Efthymiou, Georgios, additional, Ehrenfeld, Michael, additional, Elalamy, Ismail, additional, Emeršič, Nina, additional, Evelina, Kamaeva, additional, Fontana, Giulia, additional, Franceschini, Franco, additional, Fremeaux-Bacchi, Véronique, additional, Fritzler, Marvin J., additional, Galaviz-Sánchez, Maria F., additional, Ganina, K.K., additional, Gavrilova, Natalia, additional, Giacomelli, Roberto, additional, Gris, Jean-Christophe, additional, Gutierrez-Melgarejo, Caroline I., additional, Horwitz, Ehud, additional, Israeli, Eitan, additional, Jacotot, Etienne, additional, Jara, Luis J., additional, Kanduc, Darja, additional, Kessel, Christoph, additional, Khizroeva, Jamilya, additional, Kolobov, Andrei, additional, Kostoglou-Athanassiou, Ifigenia, additional, Lapin, Sergey V., additional, Lasagni, G., additional, Lerner, Aaron, additional, Lev, Danielle Zemer, additional, Lidiia, Soprun, additional, López-Zamora, Berenice, additional, Lozano, Jose Manuel, additional, Lucas Hernández, Abihai, additional, Makatsariya, Alexander, additional, Malkova, Anna, additional, Maria, Lukashenko, additional, Mayorova, Margarita A., additional, Medina, Gabriela, additional, Meroni, P.L., additional, Mevorach, Dror, additional, Muller, Sylviane, additional, N. Petrova, Natalia, additional, Nikolenko, Vladimir N., additional, Ordinola Navarro, Alberto, additional, Ordoñez-González, Irvin, additional, Paladini, Alberto, additional, Pervakova, Margarita Y., additional, Perzon, Ofer, additional, Petrova, N.V., additional, Radic, Marko, additional, Rigopoulou, Eirini I., additional, Rodrigues-Fernandes, Jorge-Manuel, additional, Rosenberg, Avi, additional, Ruscitti, Piero, additional, Ryabkova, Varvara A., additional, Saia, Rafael Simone, additional, Sankov, Sergey V., additional, Sankova, Maria V., additional, Shoenfeld, Yehuda, additional, Sinelnikov, Mikhail Y., additional, Sobolevskaia, Polina, additional, Stervbo, Ulrik, additional, Talamini, Laura, additional, Tarasov, S.A., additional, Thurner, Lorenz, additional, Tincani, Angela, additional, Tkachenko, Olga Y., additional, Tocut, M., additional, Ursini, Francesco, additional, Vera-Lastra, Olga, additional, Vieira, Angelica Thomaz, additional, Vojdani, Aristo, additional, Vojdani, Elroy, additional, Watad, Abdulla, additional, Zandman-Goddard, G., additional, Zmira, Ofir, additional, and Zohar, Daniela Noa, additional

Published
2023
Full Text
View/download PDF

22. Blood-Based Biomarkers in Frontotemporal Dementia: A Narrative Review.

Author

Liampas, Ioannis, Kyriakoulopoulou, Panagiota, Karakoida, Vasiliki, Kavvoura, Panagiota Andriana, Sgantzos, Markos, Bogdanos, Dimitrios P., Stamati, Polyxeni, Dardiotis, Efthimios, and Siokas, Vasileios

Subjects
GLIAL fibrillary acidic protein, LEWY body dementia, ALZHEIMER'S disease, TAU proteins, FRONTOTEMPORAL dementia
Abstract

This narrative review explores the current landscape of blood biomarkers in Frontotemporal dementia (FTD). Neurofilament light chain (NfL) may be useful in the differentiation of behavioral variant FTD from primary psychiatric disorders (PPDs) or dementia with Lewy bodies (DLB). In prodromal FTD and presymptomatic mutation carriers (GRN, MAPT, C9orf72), elevated NfL may herald pheno-conversion to full-blown dementia. Baseline NfL correlates with steeper neuroanatomical changes and cognitive, behavioral and functional decline, making NfL promising in monitoring disease progression. Phosphorylated neurofilament heavy chain (pNfH) levels have a potential limited role in the demarcation of the conversion stage to full-blown FTD. Combined NfL and pNfH measurements may allow a wider stage stratification. Total tau levels lack applicability in the framework of FTD. p-tau, on the other hand, is of potential value in the discrimination of FTD from Alzheimer's dementia. Progranulin concentrations could serve the identification of GRN mutation carriers. Glial fibrillary acidic protein (GFAP) may assist in the differentiation of PPDs from behavioral variant FTD and the detection of GRN mutation carriers (additional research is warranted). Finally, TAR DNA-binding protein-43 (TDP-43) appears to be a promising diagnostic biomarker for FTD. Its potential in distinguishing TDP-43 pathology from other FTD-related pathologies requires further research. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

23. Identification and characteristics of patients with potential difficult-to-treat psoriatic arthritis: exploratory analyses of the Greek PsA registry.

Author

Vassilakis, Konstantinos D, Papagoras, Charalampos, Fytanidis, Nikolaos, Gazi, Sousana, Mole, Evangelia, Krikelis, Michael, Voulgari, Paraskevi V, Kaltsonoudis, Evripidis, Koletsos, Nikolaos, Boumpas, Dimitrios, Katsimpri, Pelagia, Katsifis-Nezis, Dimitrios, Dimitroulas, Theodoros, Kougkas, Nikolaos, Boutel, Maria, Sfikakis, Petros P, Tektonidou, Maria G, Gialouri, Chrysoula, Bogdanos, Dimitrios, and Simopoulou, Theodora

Subjects
PSORIATIC arthritis, RESEARCH funding, BODY mass index, SEX distribution, ANTIRHEUMATIC agents, REPORTING of diseases, SEVERITY of illness index, DESCRIPTIVE statistics, INFLAMMATORY bowel diseases, RESEARCH, SENSITIVITY & specificity (Statistics)
Abstract

Objective To present the characteristics of patients with potential difficult-to-treat (D2T) PsA. Methods We used data from the Greek multicentre registry of PsA patients. D2T PsA was defined as follows: patients with at least 6 months' disease duration, who have failed to at least one conventional synthetic DMARD and at least two biologic DMARDs/targeted synthetic DMARDs with a different mechanism of action and have either at least moderate disease activity (MODA) defined as DAPSA (Disease Activity index in PSoriatic Arthritis) >14, and/or are not at minimal disease activity (MDA). Demographic and clinical characteristics were compared between D2T and non-D2T PsA patients. In two sensitivity analyses, patients classified as D2T solely according to the MODA or MDA criterion were examined separately. Results Among 467 patients included, 77 (16.5%) were considered D2T and 390 non-D2T PsA. Compared with non-D2T, patients with D2T PsA presented more commonly with extensive psoriasis (P  < 0.0001) and were more likely to have higher BMI (P  = 0.023) and a history of IBD (P  = 0.026). In the MODA and MDA sensitivity analyses, 7.5% and 12.5% of patients were considered D2T, respectively. In both sensitivity analyses, extensive psoriasis was again identified as an independent variable for D2T PsA (P  = 0.001 and P  = 0.008, respectively). Moreover, female gender (P  = 0.034) in the MODA analysis and axial disease (P  = 0.040) in the MDA analysis were independent variables for D2T PsA. Conclusion Despite the availability of therapies, D2T PsA is common in real-life cohorts of patients with PsA and extensive psoriasis. High BMI, female gender, axial disease and history of IBD were also associated with D2T PsA. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

26. PDE4 Gene Family Variants Are Associated with Response to Apremilast Treatment in Psoriasis

Author

Liadaki, Kalliopi, primary, Zafiriou, Efterpi, additional, Giannoulis, Themistoklis, additional, Alexouda, Sofia, additional, Chaidaki, Kleoniki, additional, Gidarokosta, Polyxeni, additional, Roussaki-Schulze, Angeliki-Viktoria, additional, Tsiogkas, Sotirios G., additional, Daponte, Athina, additional, Mamuris, Zissis, additional, Bogdanos, Dimitrios P., additional, Moschonas, Nicholas K., additional, and Sarafidou, Theologia, additional

Published
2024
Full Text
View/download PDF

28. Autoimmune Hepatitis

Author

Liaskos, Christos, Efthymiou, George, Bogdanos, Dimitrios P., Radu-Ionita, Florentina, editor, Pyrsopoulos, Nikolaos T., editor, Jinga, Mariana, editor, Tintoiu, Ion C., editor, Sun, Zhonghua, editor, and Bontas, Ecaterina, editor

Published
2020
Full Text
View/download PDF

29. Primary Sclerosing Cholangitis

Author

Koutsoumpas, Andreas L., Efthymiou, George, Mytilinaiou, Maria G., Bogdanos, Dimitrios P., Radu-Ionita, Florentina, editor, Pyrsopoulos, Nikolaos T., editor, Jinga, Mariana, editor, Tintoiu, Ion C., editor, Sun, Zhonghua, editor, and Bontas, Ecaterina, editor

Published
2020
Full Text
View/download PDF

36. Contributors

Author

Abdoli, Amir, primary, Andersen, Catherine J., additional, Badirzadeh, Alireza, additional, Banday, Aaqib Zaffar, additional, Barbosa, Arsénio, additional, Barnie, Prince Amoah, additional, Baron, Byron, additional, Bellengier, Cécilia, additional, Bjourson, Anthony J., additional, Bogdanos, Dimitrios P., additional, Borges, Tiago, additional, Dardiotis, Efthymios, additional, Duez, Hélène, additional, Egan, Phil, additional, Falak, Reza, additional, Farrugia, Mark, additional, Gibson, David S., additional, Greco, Julia M., additional, Guo, Guangran, additional, Habibi-Anbouhi, Mahdi, additional, Hajizadeh-Saffar, Ensiyeh, additional, Huard, Bertrand, additional, Izadi, Zhila, additional, Jahangir, Shahrbanoo, additional, Jindal, Ankur Kumar, additional, Kelly, Catriona, additional, Lapsley, Coral R., additional, Lin, Xia, additional, Martin, Chloe A., additional, Martins, Luísa Sales, additional, Matchett, Kyle B., additional, Mavropoulos, Athanasios, additional, McAllister, Roisin, additional, McClean, Paula, additional, McGilligan, Victoria, additional, Meamar, Ahmadreza, additional, Mirjalili, Seyedeh Zohreh, additional, Mojtabavi, Nazanin, additional, Murray, Elaine K., additional, de Oliveira, Gislane Lelis Vilela, additional, Pourcet, Benoit, additional, Pradhan, Madhulika, additional, Rai, Taranjit Singh, additional, Ramos, Stephan, additional, Rezaei, Nima, additional, Rodrigues, Guilherme Siqueira Pardo, additional, Russ, Holger A., additional, Sabourian, Reyhaneh, additional, Sakkas, Lazaros I., additional, de Salis, Larissa Vedovato Vilela, additional, Silva, Sérgio, additional, Singh, Deependra, additional, Singh, Manju Rawat, additional, Sitar, Mustafa Erinç, additional, Sturm, Nathalie, additional, Tobón, Gabriel J., additional, Tyagi, Rahul, additional, Vivas, Álvaro J., additional, Yadav, Krishna, additional, Yazdanpanah, Niloufar, additional, Zafiriou, Efterpi, additional, Zeydabadinejad, Sareh, additional, and Zhaoliang, Su, additional

Published
2022
Full Text
View/download PDF

37. Alzheimer's Disease and Effects of ABCA7 Polymorphisms: A Review.

Author

Gialama, Vaia, Siokas, Vasileios, Liampas, Ioannis, Tsouris, Zisis, Stamati, Polyxeni, Aslanidou, Paraskevi, Provatas, Antonios, Tsimourtou, Vana, Xiromerisiou, Georgia, Bogdanos, Dimitrios P., and Dardiotis, Efthimios

Subjects
ALZHEIMER'S disease, GENETIC polymorphisms, ASIANS, GENETIC variation, NEURODEGENERATION
Abstract

Alzheimer's Disease (AD) is a progressive neurodegenerative disease and the main cause of dementia. Its etiology remains largely unclear, though genetic and environmental factors appear to confer susceptibility to AD development. This study assessed the role of ATP-binding Cassette A Subfamily 7 (ABCA7) genetic polymorphisms, as ongoing research suggests they have a role in the development of AD. We conducted a PubMed, Google Scholar, and Scopus search to identify and assess all AD studies examining ABCA7 variants in different populations and ethnicities. The last search was conducted on February 8, 2023. Inclusion and exclusion criteria were applied and only the studies that met the inclusion criteria were included in this review. Seventeen studies were finally included. According to the results, ABCA7 variants infer different risks for AD among populations with different ancestries. African American populations show a higher risk for AD, carrying the five novel variants rs115550680, rs142076058, rs10405305, rs3764647, and rs567222111. Asian populations also have an increased risk for AD, harboring three variants. ABCA7 genetic variability contributes to AD development and shows racial disparities. African American and Asian populations seem to be at greater risk of developing AD. These results may assist future research efforts for the early and accurate diagnosis of AD. Moreover, further exploration of the mechanisms of ABCA7 in the context of AD could identify potential therapeutic targets. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

40. Combined Effects of Physical Activity and Diet on Cancer Patients: A Systematic Review and Meta-Analysis.

Author

Dinas, Petros C., Karaventza, Marianthi, Liakou, Christina, Georgakouli, Kalliopi, Bogdanos, Dimitrios, and Metsios, George S.

Abstract

Background: The purpose of our systematic review was to examine the effects of any physical activity/exercise intervention combined with any diet/nutrition intervention on any biological/biochemical index, quality of life (QoL), and depression in breast, lung, colon and rectum, prostate, stomach, and liver cancer patients and/or cancer survivors. Methods: A systematic review and meta-analysis were undertaken, using PRISMA guidelines and the Cochrane Handbook. The systematic review protocol can be found in the PROSPERO database; registration number: CRD42023481429. Results: We found moderate-quality evidence that a combined intervention of physical activity/exercise and nutrition/diet reduced body mass index, body weight, fat mass, insulin, homeostatic model assessment for insulin resistance, C-reactive protein, triglycerides, and depression, while it increased high-density lipoprotein, the physical component of QoL, and general functional assessment of cancer therapy. Conclusions: We conclude that a combined intervention of physical activity/exercise and diet/nutrition may decrease body weight, fat mass, insulin levels, and inflammation, and improve lipidemic profile, the physical component of QoL, and depression in cancer patients and survivors. These outcomes indicate a lower risk for carcinogenesis; however, their applicability depends on the heterogeneity of the population and interventions, as well as the potential medical treatment of cancer patients and survivors. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

41. Risk of multiple sclerosis in patients with psoriasis receiving anti‐IL‐17 agents: A case‐based review.

Author

Tsiogkas, Sotirios G., Tsimourtou, Vaia, Chaidaki, Kleoniki, Dardiotis, Efthymios, Roussaki‐Schulze, Angeliki Victoria, Bogdanos, Dimitrios P., and Zafiriou, Efterpi

Abstract

Biologics approved for psoriasis exhibit favorable safety profiles, and serious adverse events have rarely been reported. In this report, we present the case of a patient treated with ixekizumab, an anti‐interleukin (IL)‐17 agent, who 8 months later developed multiple sclerosis (MS). We also review the available literature regarding the use of anti‐IL‐17 agents in the context of psoriasis and pre‐existing or new‐onset demyelination. Eight case reports were evaluated as relevant and are presented in our report. In most of the cases secukinumab or ixekizumab administration adequately controlled both skin and pre‐existing neurological clinical manifestations. However, there has been a report of MS exacerbation under secukinumab treatment and the occurrence of myelitis in a patient receiving ixekizumab. While the anti‐IL‐17‐biologic‐mediated induction of inflammatory events in the central nervous system has not been proven and a causal relationship is lacking, such a probability should be considered in extremely rare cases. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

45. Pesticides, cognitive functions and dementia: A review

Author

Aloizou, Athina-Maria, Siokas, Vasileios, Vogiatzi, Christina, Peristeri, Eleni, Docea, Anca Oana, Petrakis, Demetrios, Provatas, Antonios, Folia, Vasiliki, Chalkia, Charikleia, Vinceti, Marco, Wilks, Martin, Izotov, Boris N., Tsatsakis, Aristidis, Bogdanos, Dimitrios P., and Dardiotis, Efthimios

Published
2020
Full Text
View/download PDF

47. Beat the Clock: Assessment of Night Eating Syndrome and Circadian Rhythm in a Sample of Greek Adults

Author

Blouchou, Anastasia, primary, Chamou, Vasiliki, additional, Eleftheriades, Christos, additional, Poulimeneas, Dimitrios, additional, Kontouli, Katerina-Maria, additional, Gkiouras, Konstantinos, additional, Bargiota, Alexandra, additional, Gkouskou, Kalliopi K., additional, Rigopoulou, Eirini, additional, Bogdanos, Dimitrios P., additional, Goulis, Dimitrios G., additional, and Grammatikopoulou, Maria G., additional

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results